Philips' Intelligent Pill Targets Drug Development And Treatment For Digestive Tract Diseases At this week's opening of the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition (Atlanta, USA, November 16-20, 2008) Philips Research will announce its new intelligent pill technology "iPill", targeted at assisting drug development and enabling new therapies for debilitating and life-threatening digestive tract disorders such as Crohn's disease, colitis and colon cancer.
Source: www.medicalnewstoday.comDronedarone (Multaq(R)) Reduced The Incidence And Duration Of Hospitalization In Patients With Atrial Fibrillation New data from the landmark ATHENA trial showed that dronedarone significantly reduced the incidence and total duration of hospital stays among patients with atrial fibrillation/atrial flutter (AF/AFL). This post-hoc analysis was presented at the 2008 American Heart Association Scientific Sessions in New Orleans, Louisiana. In this new analysis, dronedarone significantly reduced the total number of hospital days by 28 percent (p
Source: www.medicalnewstoday.com
# posted by Network @ 1:00 PM
